Detalhe da pesquisa
1.
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.
Ann Oncol
; 20(11): 1842-7, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19406901